Canine Da2Ppv+Cv Alu Adj Lv+Kv
22 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
5
Deaths Reported
2270.0%
Death Rate
Active Ingredients
Canine Da2Ppv+Cv Alu Adj Lv+Kv
Administration Routes
SubcutaneousUnknown
Species Affected
Dog 22
Most Affected Breeds
Shih Tzu 3
Rottweiler 3
Mountain Dog - Bernese 3
Bulldog 3
Terrier (unspecified) 2
Doberman Pinscher 2
Terrier - Yorkshire 1
Bulldog - French 1
Crossbred Canine/dog 1
Maltese 1
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 7
Vomiting 6
Diarrhoea 5
Anorexia 4
Death 4
Lack of efficacy - NOS 3
Other abnormal test result NOS 3
Lack of efficacy (virus) - NOS 3
Unable to stand 2
Ataxia 2
Emesis 2
Pale mucous membrane 2
Outcome Breakdown
Recovered/Normal
10 (37.0%)
Ongoing
7 (25.9%)
Outcome Unknown
5 (18.5%)
Died
5 (18.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.